# Cullinan Therapeutics, Inc.: Form 8-K, filed Oct 16, 2024

- Company: [Cullinan Therapeutics, Inc.](/companies/cgem.md) (CIK 1789972)
- Form: 8-K
- Filed: 2024-10-16
- Accepted by EDGAR: Oct 16, 2024, 11:17 ET
- Period: 2024-10-16
- Accession: 0000950170-24-114841
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1789972/000095017024114841/cgem-20241016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1789972/000095017024114841/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1789972/000095017024114841/cgem-20241016.htm

Filed Oct 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-114841. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.